Prune
Otherdaily consumption of 50 grams prune.
NCT Number: NCT04785131
The primary objective of this study is to determine if 12 months of consuming 50 grams of dried plum daily will prevent bone loss or augment bone accrual of young adult oral contraceptive (OC) users.
Looking for future studies?
Notify Me18 year–25 year
Female
Interventional
Not applicable
School of Exercise and Nutritional Sciences, San Diego, California, United States
Eligible participants will be assigned among three groups 1) control non-OC users, 2) control OC users, and 3) dried plum OC users. OC users will be randomly allocated to the dried plum OC group, which will consume 50 g dried plum daily for 12 months, or a control group, for which dried plums will not be allowed and no control food will be provided.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
daily consumption of 50 grams prune.
Time frame: At baseline, at 12 months
Bone density measurements with DXA
Time frame: At baseline, at 6 months, at 12 months
Bone biomarkers measurements with ELISA
San Diego State University
Other
The Impact of Consuming California Dried Plums on Bone Health of Young Women Using Hormonal Contraceptives
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06279078
Asthma, Bone Diseases
Suwon, Gyeonggi-do, South Korea
View Trial DetailsNCT05245097
Bone Diseases, Bone Diseases, Metabolic
Sacramento, California, United States
View Trial DetailsNCT06238037
Hemic and Lymphatic Diseases, Hypersensitivity
Aarhus N, Denmark
View Trial DetailsNCT05903820
Menopause, Osteoporosis Risk
Amsterdam, Netherlands
View Trial Details